SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around upcoming staking updates and airdrop details, creating excitement. The community buzzes about token burns, achieving new milestones, and the potential for future utilities. Brokecoin continues to gain traction within the Solana meme coin ecosystem, fueled by a dedicated community and ongoing development efforts.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is trending as chatter focuses on Donald Trump's alleged connections to the Epstein case, with community members debating the validity and implications of related documents. Some are defending Trump, claiming the accusations are a hoax, while others criticize his associations and economic policies. The stock's performance and broader economic concerns under the current administration are also being discussed.

Memecoin on Injective taken over by the community.

Nonja

$NONJA.X is trending as the community rallies around its strong performance within the Injective ecosystem and its potential for high gains. Bullish sentiment is fueled by the anticipation of a staked $INJ ETF, which some believe could drive further momentum for this memecoin. Community members are actively discussing its unique features, such as the burned liquidity pool, and its potential to outperform other meme coins.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

TROLL.X is trending following news of the Solana memecoin officially acquiring rights to the Trollface meme, leading to a surge in market cap. The community is discussing its potential for significant gains, drawing comparisons to other successful meme coins and highlighting its strong community. Some users are also pointing to $GASH.X as another coin with similar potential.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAL is trending as the community discusses its potential in early cancer detection, highlighted by a recent article and a story about its life-saving importance. Some traders are taking profits, anticipating a retest, while others see long-term potential, particularly with possible FDA approval and broader access to its Galleri test. Volume and news catalysts are key talking points for future price movement.

Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad’s CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Align Technology, Inc.

ALGN is trending as the community discusses recent price movement and future prospects, with some users drawing comparisons to SmileDirectClub's bankruptcy. Bullish investors point to share buybacks and insider buying as potential catalysts, while bears cite concerns about competition and market saturation. Discussions also include potential price targets and reactions to news from analysts.

WorldFinancial

World Liberty Financial (WLFI.X) is trending as the community discusses its potential role in revolutionizing finance, particularly through its USD1 stablecoin and tokenized real estate initiatives, with some highlighting potential conflicts involving Justin Sun. Community members are debating the token's long-term prospects, its ties to the Trump family, and its relationship with ALTS.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the U.S. Department of Commerce selected it to verify and distribute economic data onchain. The community is discussing its potential to disrupt the oracle space and integrate with DeFi protocols, drawing comparisons to Chainlink and CRO. Some users are speculating on price targets and anticipating the next leg up.

USELESS

$USELESS.X is gaining attention, with community members highlighting the potential for significant gains, referencing a possible 2000% move. Bullish sentiment seems to be driven by the coin's low market cap and community excitement around its potential, especially compared to other memecoins. Some users suggest that whales are accumulating $USELESS.X, anticipating a substantial pump.

Cyngn, Inc. engages in the development of autonomous driving software that can be deployed on multiple vehicle types in various environments. The company was founded by Kirt McMaster and Steve Kondik in 2013 and is headquartered in Mountain View, CA.

Cyngn Inc

CYN is trending due to a recent $300M mixed securities shelf offering, sparking concerns among investors about potential dilution and reverse stock splits. The community is actively discussing the implications of this offering, its effect on the stock's price, and the company's long-term financial stability. Despite a collaboration with NVIDIA, the stock's history of dilution and reverse splits remains a key point of discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates

Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Lags Revenue Estimates

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Tops Revenue Estimates

Shares of Optinose, Inc. (OPTN) rocketed about 55% on Thursday after privately held Paratek Pharmaceuticals <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.optinose.com/news-releases/news-release-details/paratek-pharmaceuticals-acquire-optinose-creating-significant">announced</a> that it would buy the company for up to $330 million.The two companies have entered into a definitive merger agreement, under which Paratek will acquire Optinose and its product XHANCE, a drug-device combination product approved for the treatment of Chronic rhinosinusitis.Paratek will acquire Optinose's outstanding shares for $9 apiece in cash, representing a 50% premium to Optinose’s closing trading price of $6 on March 19, and up to $5 per share in contingent value rights (CVRs) if XHANCE achieves certain net revenue milestones.Paratek said in a statement that the boards of both companies have unanimously approved the transaction. It added that the transaction is expected to close as early as mid-2025, subject to customary closing conditions and approval by Optinose shareholders.Upon completion of the transaction, Optinose will be delisted from the NASDAQ Global market.Following the announcement, Optinose also <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.optinose.com/news-releases/news-release-details/optinose-cancels-fourth-quarter-and-full-year-2024-earnings-call">canceled</a> its earnings call for the fourth quarter of 2024, which was originally scheduled for March 20.Optinose CEO Ramy Mahmoud said that Paratek, with its commercial and medical capabilities, has the potential to increase awareness for Optinose’s XHANCE.“We are excited about the many ways in which this transaction creates opportunities for XHANCE to help more patients achieve better symptom control while creating near- and long-term value for Optinose's shareholders," he said.Paratek, meanwhile, said that the acquisition will help the company expand its portfolio.On Stocktwits, retail investor sentiment flipped from ‘extremely bearish’ to ‘extremely bullish’ (100/100) territory within the past 24 hours, coupled with ‘extremely high’ message volume.<figure class="image"><img style="aspect-ratio:810/181;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_03_20_115139_png_df0e5340e2.webp" alt="Optinose’s Sentiment Meter and Message Volume as of 11:50 a.m. ET on March 20, 2025 | Source: Stocktwits" width="810" height="181"><figcaption>Optinose’s Sentiment Meter and Message Volume as of 11:50 a.m. ET on March 20, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/OPTN">Optinose shares</a> are up over 38% in 2025 but have lost over 60% in the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/geo-stock-rises-on-ice-contract/ch7Nru4RbPQ">GEO Stock Rises On Immigration And Customs Contract With Annualized Revenue Potential Of $70M: Retail’s On The Fence</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Retail investors on Stocktwits — where Altimmune has over 36,000 followers — have long speculated that the company could be a takeover target. | Image source: Getty Images

Optinose Shares Soar After Merger Agreement With Paratek Pharmaceuticals: Retail Sentiment Takes Flight 

Paratek will acquire Optniose's outstanding shares for $9 apiece in cash, representing a 50% premium to the stock’s closing trading price of $6 on March 19.

Equity

Paratek will acquire Optinose's outstanding shares for $9 apiece in cash, representing a 50% premium to the stock’s closing trading price of $6 on March 19, and up to $5 per share in contingent value rights if XHANCE achieves certain net revenue milestones.


Insights Ahead: OptiNose's Quarterly Earnings

Optinose to Present at the Needham Virtual Healthcare Conference

YARDLEY, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...

Ramy A. Mahmoud Sells 19,198 Shares of OptiNose, Inc. (NASDAQ:OPTN) Stock

OptiNose, Inc. (NASDAQ:OPTN  Get Free Report) CEO Ramy A. Mahmoud sold 19,198 shares of the stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price...

Lake Street Capital Boosts OptiNose (NASDAQ:OPTN) Price Target to $4.00

OptiNose (NASDAQ:OPTN  Free Report) had its price target raised by Lake Street Capital from $3.00 to $4.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage...

OptiNose (NASDAQ:OPTN) PT Raised to $4.00

OptiNose (NASDAQ:OPTN  Free Report) had its price target raised by Lake Street Capital from $3.00 to $4.00 in a report published on Monday, Benzinga reports. The brokerage currently has a buy...

Optinose price target raised by $1 at Lake Street, here's why

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.

OPTN
OptiNose Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OPTN News

OPTN OptiNose Inc